Abstract We describe a medicinal chemistry approach for generating a series of 2-(1H- pyrazol-1-yl) thiazoles as EP 1 receptor antagonists. To improve the physicochemical properties of compound 1, we investigated its structure–activity relationships (SAR). Optimization of this lead compound provided small compound 25 which exhibited the best EP 1 receptor antagonist activity and a good SAR profile.
[Meanwell, Nicholas A.; Rosenfeld, Michael J.; Wright, J. J. Kim; Brassard, Catherine L.; Buchanan, John O.; et al. Journal of Medicinal Chemistry, 1992 , vol. 35, # 2 p. 389 - 397]